223 related articles for article (PubMed ID: 29684592)
21. Efficient siRNA Delivery Using Novel Cell-Penetrating Peptide-siRNA Conjugate-Loaded Nanobubbles and Ultrasound.
Xie X; Lin W; Li M; Yang Y; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
Ultrasound Med Biol; 2016 Jun; 42(6):1362-74. PubMed ID: 27012462
[TBL] [Abstract][Full Text] [Related]
22. Dual stimulus of hyperthermia and intracellular redox environment triggered release of siRNA for tumor-specific therapy.
Yang Y; Yang Y; Xie X; Xu X; Xia X; Wang H; Li L; Dong W; Ma P; Liu Y
Int J Pharm; 2016 Jun; 506(1-2):158-73. PubMed ID: 27106526
[TBL] [Abstract][Full Text] [Related]
23. Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells.
Imani R; Shao W; Taherkhani S; Emami SH; Prakash S; Faghihi S
Colloids Surf B Biointerfaces; 2016 Nov; 147():315-325. PubMed ID: 27543693
[TBL] [Abstract][Full Text] [Related]
24. Photolabile-caged peptide-conjugated liposomes for siRNA delivery.
Xie X; Yang Y; Yang Y; Mei X
J Drug Target; 2015; 23(9):789-99. PubMed ID: 25675844
[TBL] [Abstract][Full Text] [Related]
25. Development of elastin-like polypeptide for targeted specific gene delivery in vivo.
Yi A; Sim D; Lee YJ; Sarangthem V; Park RW
J Nanobiotechnology; 2020 Jan; 18(1):15. PubMed ID: 31952530
[TBL] [Abstract][Full Text] [Related]
26. A non-covalent peptide-based strategy for siRNA delivery.
Crombez L; Divita G
Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
[TBL] [Abstract][Full Text] [Related]
27. VEGF siRNA Delivery by a Cancer-Specific Cell-Penetrating Peptide.
Lee YW; Hwang YE; Lee JY; Sohn JH; Sung BH; Kim SC
J Microbiol Biotechnol; 2018 Mar; 28(3):367-374. PubMed ID: 29316746
[TBL] [Abstract][Full Text] [Related]
28. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
Li H; Tsui TY; Ma W
Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
[TBL] [Abstract][Full Text] [Related]
29. Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.
Yang ZZ; Li JQ; Wang ZZ; Dong DW; Qi XR
Biomaterials; 2014 Jun; 35(19):5226-39. PubMed ID: 24695093
[TBL] [Abstract][Full Text] [Related]
30. Characterization and evaluation of a peptide-based siRNA delivery system in vitro.
Chen B; Yoo K; Xu W; Pan R; Han XX; Chen P
Drug Deliv Transl Res; 2017 Aug; 7(4):507-515. PubMed ID: 28349343
[TBL] [Abstract][Full Text] [Related]
31. Cell targeting peptide conjugation to siRNA polyplexes for effective gene silencing in cardiomyocytes.
Nam HY; Kim J; Kim SW; Bull DA
Mol Pharm; 2012 May; 9(5):1302-9. PubMed ID: 22452378
[TBL] [Abstract][Full Text] [Related]
32. Lauroylated Histidine-Enriched S4
Morais CM; Cardoso AM; Aguiar L; Vale N; Nóbrega C; Zuzarte M; Gomes P; Pedroso de Lima MC; Jurado AS
Pharm Res; 2020 Sep; 37(10):188. PubMed ID: 32888084
[TBL] [Abstract][Full Text] [Related]
33. siRNA-cell-penetrating peptides complexes as a combinatorial therapy against chronic myeloid leukemia using BV173 cell line as model.
Freire JM; Rego de Figueiredo I; Valle J; Veiga AS; Andreu D; Enguita FJ; Castanho MA
J Control Release; 2017 Jan; 245():127-136. PubMed ID: 27890856
[TBL] [Abstract][Full Text] [Related]
34. Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles.
Wang L; Hao Y; Li H; Zhao Y; Meng D; Li D; Shi J; Zhang H; Zhang Z; Zhang Y
J Drug Target; 2015; 23(9):832-46. PubMed ID: 25856302
[TBL] [Abstract][Full Text] [Related]
35. Targeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice.
Wang XL; Xu R; Wu X; Gillespie D; Jensen R; Lu ZR
Mol Pharm; 2009; 6(3):738-46. PubMed ID: 19296675
[TBL] [Abstract][Full Text] [Related]
36. Cell-penetrating peptide mimicking polymer-based combined delivery of paclitaxel and siRNA for enhanced tumor growth suppression.
Jang YL; Yun UJ; Lee MS; Kim MG; Son S; Lee K; Chae SY; Lim DW; Kim HT; Kim SH; Jeong JH
Int J Pharm; 2012 Sep; 434(1-2):488-93. PubMed ID: 22613208
[TBL] [Abstract][Full Text] [Related]
37. PEGylation rate influences peptide-based nanoparticles mediated siRNA delivery in vitro and in vivo.
Aldrian G; Vaissière A; Konate K; Seisel Q; Vivès E; Fernandez F; Viguier V; Genevois C; Couillaud F; Démèné H; Aggad D; Covinhes A; Barrère-Lemaire S; Deshayes S; Boisguerin P
J Control Release; 2017 Jun; 256():79-91. PubMed ID: 28411182
[TBL] [Abstract][Full Text] [Related]
38. Targeting neuronal nitric oxide synthase by a cell penetrating peptide Tat-LK15/siRNA bioconjugate.
Peng J; Rao Y; Yang X; Jia J; Wu Y; Lu J; Tao Y; Tu W
Neurosci Lett; 2017 May; 650():153-160. PubMed ID: 28450191
[TBL] [Abstract][Full Text] [Related]
39. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
[TBL] [Abstract][Full Text] [Related]
40. pH-responsive PepFect cell-penetrating peptides.
Regberg J; Vasconcelos L; Madani F; Langel Ü; Hällbrink M
Int J Pharm; 2016 Mar; 501(1-2):32-8. PubMed ID: 26821060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
